点击图片查看原图
人皮杆菌
肠球菌显色培养基
Thermo微生物鉴定及药敏检测仪
[VIP第1年] 指数:2
通过闵行区市场监督管理局认证 
过氧化氢酶-Catalase
溶菌酶干粉-Lysozyme 
小鼠抗V5标签单抗-Ant
鲑鱼精DNA溶液,10mg/m
JM107菌种-JM107 E.co
Human TAF13 (TATA Bo
MFC细胞小鼠前胃癌细| 货号： | QD-182 |
| 保存条件： | 详见官方网站 |
| 供应商： | 钰博生物 |
| 保质期： | 详见说明书 |
| 英文名： | Cobra Venom Factor |
| 数量： | 大量 |
For Research Use Only. Not for use in diagnostic procedures.
Cobra Venom Factor (CVF), sometimes referred to as C3b (Cobra), is the non-toxic, complement-activating component of cobra venom. Like naturally occurring human C3b, CVF forms a complex, or convertase, with complement components Factor B and Factor D. This CVFBbD convertase is capable of activating C3 in a wide variety of species via the alternative complement pathway. CVFBbD convertase is Factor H resistant and is therefore not blocked through the activity of Factor I or CR1 and can convert nearly 100% of the C3 to C3 and C5 fragments. Levels of iC3b, C3a, SC5b-9, C5a and the Factor B cleavage product Bb are all extremely high in CVF treated sera.
This product has been used in an experimental setting to deplete complement activity in vitro and in vivo. For more information contact Quidel Technical Support.
References
Agarwal, Szalai, A. The Arthus Reaction in Rodents: Species Specific Requirement of Complement, J. Immunol 164:463-468, 2000.
Vandenberg, C.W., et al. In Vivo Anti-complementary activities of the cobra venom factros form Naja and Naja haje, J. Immunol. Methods. 13(6):2870294, 1991.
Rajasinghe, H. et al. Key role of the alternative pathway in hyperacute rejection of rat hearts transplanted into fetal sheep, Transplantation. 63(3), 407-426, 1996.
Koymada, N. Bach, F. Transient complement inhibition plus T Cell immuno-suppression induces long term survival of mouse to rat cardiac xenografts, Transplantation. 6(9)1210-1215, 1998.
Features & Benefits
| Feature | Benefit |
|---|
Product Specifications
| Activity | ≥ 350 units/vial |
| Form | Liquid |
| Species | Naja naja kaouthia |
| Storage | At or below –70°C |
| Purity | > 95% by SDS-Page |
| Protein Concentrate | Approximately 1.0 mg/mL |
Ordering Information
| Catalog Number | Kit Size / Case Size |
|---|---|
| A600 | 1.0 mg |
Product Documentation
 SDS |
| Technical Data Sheet |
